|
KDM4A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.586400E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.199600E-03 |
| Normal-vs-Stage2 |
2.350600E-04 |
| Normal-vs-Stage3 |
3.211500E-04 |
| Normal-vs-Stage4 |
6.336200E-03 |
| Stage1-vs-Stage2 |
6.578100E-02 |
| Stage1-vs-Stage3 |
1.150760E-01 |
| Stage1-vs-Stage4 |
5.540800E-01 |
| Stage2-vs-Stage3 |
5.451000E-01 |
| Stage2-vs-Stage4 |
2.583800E-01 |
| Stage3-vs-Stage4 |
4.915800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.209300E-04 |
| Normal-vs-AfricanAmerican |
2.532300E-02 |
| Normal-vs-Asian |
5.323600E-01 |
| Caucasian-vs-AfricanAmerican |
8.592400E-01 |
| Caucasian-vs-Asian |
6.493800E-02 |
| AfricanAmerican-vs-Asian |
1.526810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.38319999999304E-05 |
| Normal-vs-Female |
4.593700E-02 |
| Male-vs-Female |
5.383200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.983580E-01 |
| Normal-vs-Age(41-60Yrs) |
3.580200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.077630E-03 |
| Normal-vs-Age(81-100Yrs) |
1.52109000000067E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.285000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.881800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.865600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.185200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.579800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.441900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.797800E-01 |
| Normal-vs-Grade 2 |
3.417100E-03 |
| Normal-vs-Grade 3 |
2.230500E-04 |
| Normal-vs-Grade 4 |
1.340270E-02 |
| Grade 1-vs-Grade 2 |
1.155920E-02 |
| Grade 1-vs-Grade 3 |
2.797800E-03 |
| Grade 1-vs-Grade 4 |
7.697700E-02 |
| Grade 2-vs-Grade 3 |
2.366000E-01 |
| Grade 2-vs-Grade 4 |
9.090000E-01 |
| Grade 3-vs-Grade 4 |
3.342400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.828000E-04 |
| Normal-vs-ccB subtype |
1.860630E-03 |
| ccA subtype-vs-ccB subtype |
9.868000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.014600E-04 |
| Normal-vs-N1 |
7.677800E-01 |
| N0-vs-N1 |
2.618200E-01 |
|
|
